(140) discovered that selenium-containing nanocarriers could enhance the expression of NKG2D on the surface of NK cells and increase the expression of NKG2DL on tumor cell surfaces, thus improving the ability of NK cells to recognize and kill tumor cells, and enhancing their antitumor immune effects. The gene discussed is KLRK1; the disease is neoplasm.